AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymag M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Magma Allianz Laboratories Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glymag M 80mg/500mg Tablet

Diabetic patients using Glymag M 80mg/500mg tablets should be aware that this anti-diabetic medication combines two active ingredients to manage type 2 diabetes in adults. This dual-action formulation aids in regulating blood glucose. Consistent daily use, always with food, at the same time each day, is crucial for optimal efficacy. Dosage adjustments are determined by your physician based on your blood sugar response. Discontinuation without medical guidance is strongly discouraged, as it may lead to elevated blood sugar, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb loss. Glymag M 80mg/500mg tablets are only one component of a comprehensive diabetes management plan; diet, exercise, and weight management, as directed by your doctor, are equally important. Common side effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary snacks, juice) is essential for hypoglycemia management. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Less frequent side effects may include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. Glymag M 80mg/500mg tablets are contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Glymag M 80mg/500mg Tablet

The provided text is "undefined". Therefore, no rephrasing is possible.

Uses of Glymag M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glymag M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Glymag M 80mg/500mg tablets should be administered with a meal.

Common Side effects of Glymag M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glymag M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glymag M 80mg/500mg tablets should be administered with a meal.

How Glymag M 80mg/500mg Tablet works:

Gliclazide and Metformin, combined in Glymag M 80mg/500mg tablets, offer a dual-action approach to diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glymag M 80mg/500mg tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glymag M 80mg/500mg tablets during pregnancy poses a known risk to the fetus. Therefore, it's contraindicated, except in rare, life-threatening circumstances where the potential benefits outweigh the clear risks. Always seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glymag M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glymag M 80mg/500mg tablets, as dosage modification may be necessary. Severe kidney disease contraindicates the use of Glymag M 80mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Glymag M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; the medication is unsuitable for individuals with severe liver disease.

What if you forget to take Glymag M 80mg/500mg Tablet :

Should you forget a Glymag M 80mg/500mg Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glymag M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glymag M 80mg/500mg Tablet

Glymag M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glymag M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glymag M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Glymag M 80mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Glymag M 80mg/500mg and seek immediate medical attention.
Prolonged use of Glymag M 80mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Glymag M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Glymag M 80mg/500mg tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Glymag M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glymag M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glymag M 80mg/500mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glymag M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glymag M 80mg/500mg and seek immediate medical attention.
Prolonged Glymag M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glymag M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Glymag M 80mg/500mg tablets is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glymag M 80mg/500mg Table...
48
MRP 58
17% off